London, UK, 16 April 2007: BioProgress plc (the ‘Company’) (AIM: BPRG; NASDAQ: BPRG), the specialty pharmaceutical and healthcare company, is pleased to announce that it has appointed Nomura Code Securities Limited (‘Nomura Code’) as its Broker and Nominated Adviser with immediate effect. Nomura Code has been appointed because of its strength in the life sciences sector which the Company believes will be beneficial as its business develops.
